H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
Across filings in selected periodTop Employers
Hiring This RoleSee all H-1B/PERM filings for this role →
| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | 2 | $155,012 | $141,170 - $168,854 | 100.0% |
| Otsuka America Pharmaceutical, Inc. | 2 | $160,000 | $150,000 - $170,000 | 50.0% |
| BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 1 | $182,065 | $182,065 - $182,065 | 100.0% |
| Genzyme Corporation | 1 | $118,965 | $118,965 - $118,965 | 100.0% |
| Takeda Pharmaceuticals USA Inc. | 1 | $184,625 | $184,625 - $184,625 | 100.0% |
| Experience Level | Filings | Median Salary | Salary Range |
|---|---|---|---|
| Director | 7 | $168,854 | $118,965 - $184,625 |
| City | State | Filings | Median Salary |
|---|---|---|---|
| East Hanover | NJ | 2 | $155,012 |
| Princeton | NJ | 2 | $160,000 |
| Cambridge | MA | 1 | $184,625 |
| Ridgefield | CT | 1 | $182,065 |
These roles are variations of Associate Director, Forecasting with different seniority levels.
| Role | Experience Level | Filings | Avg Salary |
|---|---|---|---|
| Associate Director, Forecasting | 11 | $145,645 | |
| Associate Director Forecasting (Strategy and Planning) | 1 | $184,625 | |
| ASSOCIATE, FORECASTING | Unspecified | 1 | $65,000 |
| SENIOR ASSOCIATE FORECASTING | 1 | $64,189 | |
| SR. ASSOCIATE MANAGER, FORECASTING | 1 | $89,942 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| 2022 | 1 | $182,065 | 100.0% |
| 2023 | 3 | $170,000 | 100.0% |
| 2024 | 1 | $150,000 | 0.0% |
| 2025 | 1 | $141,170 | 100.0% |
| 2026 | 1 | $118,965 | 100.0% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | 2 | $155,012 | 100.0% |
| Otsuka America Pharmaceutical, Inc. | 2 | $160,000 | 50.0% |
| BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 1 | $182,065 | 100.0% |
| Genzyme Corporation | 1 | $118,965 | 100.0% |
| Takeda Pharmaceuticals USA Inc. | 1 | $184,625 | 100.0% |